Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings, Inc.

Veeva Systems Inc ($VEEV), Medpace Holdings Inc ($MEDP) announced an update on their ongoing clinical study. The SUMMIT registry tracks long term s...

Long-Horizon DMD Registry Signals Steady Demand for VEEV and MEDP Trial Services

Jefferies analyst David Windley maintained a Hold rating on Medpace Holdings today and set a price target of $560.00. According to TipRanks, Windle...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MEDP	$617.05	-0.30%	95.44K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MEDP	$617.05	-0.3%	95.44K
3
4
5
6

MEDP

Get Medpace Holdings, Inc. Data in Excel

Get Medpace Holdings, Inc. Data in Excel